Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6616 AL 6630

A New Hope in Alzheimer's Disease Psychosis: Pimavanserin

Kurhan F, Akın M.

Curr Alzheimer Res. 2023;20(6):403-408. doi: 10.2174/1567205020666230825124922.

Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer's Disease and Parkinson's Dementia: Systematic Review and Meta-Analysis

Bittner N, Funk CSM, Schmidt A, Bermpohl F, Brandl EJ, Algharably EEA, Kreutz R, Riemer TG.

Drugs Aging. 2023 Nov;40(11):953-964. doi: 10.1007/s40266-023-01065-x. Epub 2023 Sep 8.

Protocol of a randomized controlled trial investigating Deep Brain Stimulation for MOtor symptoms in patients with Parkinson's disease DEmentia (DBS-MODE)

Sisodia V, Swinnen BEKS, Dijk JM, Verwijk E, van Rooijen G, Lemstra AW, Schuurman PR, de Bie RMA.

BMC Neurol. 2023 Apr 21;23(1):160. doi: 10.1186/s12883-023-03142-5.

Repurposing and clinical attributes of antidiabetic drugs for the treatment of neurodegenerative disorders

Birajdar SV, Mazahir F, Alam MI, Kumar A, Yadav AK.

Eur J Pharmacol. 2023 Dec 15;961:176117. doi: 10.1016/j.ejphar.2023.176117. Epub 2023 Oct 30.

Sigma-2 Receptors-From Basic Biology to Therapeutic Target: A Focus on Age-Related Degenerative Diseases

Lizama BN, Kahle J, Catalano SM, Caggiano AO, Grundman M, Hamby ME.

Int J Mol Sci. 2023 Mar 26;24(7):6251. doi: 10.3390/ijms24076251.

Molecular mechanisms of neuroprotective offerings by rosmarinic acid against neurodegenerative and other CNS pathologies

Ravaria P, Saxena P, Laksmi Bs S, Ranjan V, Abidi SWF, Saha P, Ramamoorthy S, Ahmad F, Rana SS.

Phytother Res. 2023 May;37(5):2119-2143. doi: 10.1002/ptr.7825. Epub 2023 Apr 4.

Therapeutic implications of phosphorylation- and dephosphorylation-dependent factors of cAMP-response element-binding protein (CREB) in neurodegeneration

Khakha N, Khan H, Kaur A, Singh TG.

Pharmacol Rep. 2023 Oct;75(5):1152-1165. doi: 10.1007/s43440-023-00526-9. Epub 2023 Sep 9.

Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine

Jin S, Zhang L, Wang L.

Biomed Pharmacother. 2023 Sep;165:115215. doi: 10.1016/j.biopha.2023.115215. Epub 2023 Jul 24.

Challenges and Discoveries in Polypharmacology of Neurodegenerative Diseases

Lustoza Rodrigues TCM, de Sousa NF, Dos Santos AMF, Aires Guimarães RD, Scotti MT, Scotti L.

Curr Top Med Chem. 2023;23(5):349-370. doi: 10.2174/1568026623666230126112628.

Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders

Almikhlafi MA, Karami MM, Jana A, Alqurashi TM, Majrashi M, Alghamdi BS, Ashraf GM.

Curr Neuropharmacol. 2023;21(5):1165-1183. doi: 10.2174/1570159X20666220830112408.

Cyclitols: From Basic Understanding to Their Association with Neurodegeneration

Derkaczew M, Martyniuk P, Osowski A, Wojtkiewicz J.

Nutrients. 2023 Apr 23;15(9):2029. doi: 10.3390/nu15092029.

Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases

Wang Y, Lv MN, Zhao WJ.

Ageing Res Rev. 2023 Nov;91:102035. doi: 10.1016/j.arr.2023.102035. Epub 2023 Aug 22.

Exosomes for the diagnosis and treatment of dementia

Joo HS, Jeon HY, Hong EB, Kim HY, Lee JM.

Curr Opin Psychiatry. 2023 Mar 1;36(2):119-125. doi: 10.1097/YCO.0000000000000842. Epub 2023 Jan 11.

The Alteration of Neurogenesis and Pathological Markers in Alzheimer's Disease After Deep Brain Stimulation

Nassehi B, Kocabicak E, Temel Y, Hescham S.

Turk Neurosurg. 2022;32(4):535-548. doi: 10.5137/1019-5149.JTN.35598-21.2.

A Review on Chitosan in Drug Delivery for Treatment of Neurological and Psychiatric Disorders

Shayganfard M.

Curr Pharm Biotechnol. 2022;23(4):538-551. doi: 10.2174/1389201022666210622111028.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias